Oncodea
Oncodea is a biotechnology company focused on revolutionizing early cancer detection. Their AI-powered platform, OncodeAI, combines molecular fingerprint data with machine learning to predict cancer in blood samples, enabling faster and more accurate diagnoses. The technology is designed to be comprehensive, affordable, and accessible, aiming to bring early cancer detection to the masses. Oncodea's approach utilizes a unique, patent-pending combination of AI/machine learning, hardware, and cell-free chemistry to analyze blood samples without relying on predefined biomarkers or genetic sequences. The platform is being developed for early detection of breast, lung, prostate, and colorectal cancer, offering a cost-effective alternative to traditional screening methods and reducing the risks associated with radiation exposure. Their mission is to accelerate AI applications in cancer detection and make cancer diagnosis more inexpensive and routine.
Oncodea
Oncodea is a biotechnology company focused on revolutionizing early cancer detection. Their AI-powered platform, OncodeAI, combines molecular fingerprint data with machine learning to predict cancer in blood samples, enabling faster and more accurate diagnoses. The technology is designed to be comprehensive, affordable, and accessible, aiming to bring early cancer detection to the masses. Oncodea's approach utilizes a unique, patent-pending combination of AI/machine learning, hardware, and cell-free chemistry to analyze blood samples without relying on predefined biomarkers or genetic sequences. The platform is being developed for early detection of breast, lung, prostate, and colorectal cancer, offering a cost-effective alternative to traditional screening methods and reducing the risks associated with radiation exposure. Their mission is to accelerate AI applications in cancer detection and make cancer diagnosis more inexpensive and routine.
TL;DR
Focus: Non-invasive, AI-driven early cancer detection using blood samples
Technology: OncodeAI: molecular fingerprinting + machine learning with patent-pending hardware and cell-free chemistry
Headquarters & founding: Twin Cities (St. Paul / Minneapolis), Minnesota; founded 2021
Funding & investors: Dec 2022 grant for USD 6,000; investors include Groove Capital and Walleye Tank
Company Overview
Problem Domain
Early-stage cancer detection; non-invasive diagnostic testing
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
USD 6,000
Investor Signal
“Investors include Groove Capital and Walleye Tank”